PTC Therapeutics, Inc.
PTC Therapeutics, Inc. (PTCT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PTCT · as of Jun 9, 2026
Key Statistics
Explore PTC Therapeutics, Inc. Data
ptct stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 26 · Buy rate: 65.4%
The PTCT analyst consensus is Buy, based on ratings from 26 Wall Street analysts over the past 3 months. The average 12-month price target is $95.83, representing +35.22% upside from the current price of $70.87.
Competitors & Peers
ptct competitorsPTCT
ACLX
ALKS
ARWR
CRNX
KRYSStock Performance
Full HistoryAbout PTC Therapeutics, Inc.
PTC Therapeutics, Inc. (PTCT) is a biopharmaceutical company committed to the research, development, and commercialization of innovative therapies for patients afflicted with rare genetic disorders. I…
what is ptc therapeutics, inc. · ptct stock overview · ptc therapeutics, inc. company profile · who is ptc therapeutics, inc. ceo · ptct NASDAQ · ptc therapeutics, inc. headquarters · ptc therapeutics, inc. business segments
About Stock Overview & Key Data
PTC Therapeutics, Inc. (PTCT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 20, 2013. As of the latest trading session, PTCT stock price is $70.87, with a market capitalization of $5.9B. The stock has returned +35.67% over the past 12 months and -7.68% year-to-date.
According to 26 Wall Street analysts, the consensus rating for PTC Therapeutics, Inc. stock is Buy, with an average 12-month price target of $95.83. In fiscal year 2025, PTC Therapeutics, Inc. reported revenue of $1.7B and net income of $682.6M. For detailed data — including PTC Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, PTC Therapeutics, Inc. (PTCT) stock price is $70.87. The stock is traded on NASDAQ under the ticker symbol PTCT. The 52-week range is $43.17 – $87.50.